OHDSI Home | Forums | Wiki | Github

Characterization of Oral Antibiotic and Isotretinoin Therapy for Acne

Researchers
#1

Dear OHDSI Community,

As a followup to our January presentation for the “Characterization of Oral Antibiotic and Isotretinoin Therapy for Acne” study, we present our protocol and we would be pleased to have your respective feedbacks, as we are looking to finalize the protocol shortly. We request that feedback be provided by May 4, 2020 so that we have time to accept and finalize each of your inputs. In the meantime, we will be updating and completing our concept sets for the study.

Please see the full details of our study on the wiki, where a link to the old discussion thread can also be found: https://www.ohdsi.org/web/wiki/doku.php?id=research:characterization_of_oral_antibiotics_for_acne_treatment

For those that have contributed to our study thus far, thank you! We look forward to working with you and other community members. Please feel free to to respond to this thread should you have any questions.

Sincerely,

Lisa, Robert, Megan, and Chandler

#2

@MauraBeaton, @Patrick_Ryan, @Andrew, @mattspotnitz, @cukarthik, @schuemie @krfeeney @Daniel_Prieto @edburn @frenyb
Hi everyone, we want to do a non-COVID (non-pernio) study–it has been in the work for a while. If you or any of your faculty are interested please pass this on to them. Thanks, all of us

#3

Your colleagues at Columbia continue to have interest in this study. Please let us know if there is anything we can do to support your research efforts. @schillil

#4

Hey OHDSI Community-
Any interest in this study? We’ve got a few dermatologists from UPenn and GeorgeWashington invovled this study, are they any OMOP/OHDSI data folks from Penn or GW on the forums
@Mary_Regina_Boland, @jinghuang – we thought you might be at Penn- let use know, as it would be great if your institution could participate as a data partner.
Lisa

1 Like
#5

Hi Lisa and other dermatology loving people
We, LEO Science&Technology Hub, are interested in doing a proof-of-concept EMR study. Understanding clinical characteristics of the patents non-responsive to eczema and psoriasis biologics therapies would be probably most interesting.
If it sounds appealing, drop me e-mail at vladimir.morozov@leo-scitech.com
Best
Vlad

t